NCT02512354View on ClinicalTrials.gov

Contribution of High-throughput Exome Sequencing in the Diagnosis of the Cause Fetal Polymalformation Syndromes

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

March 4, 2015

Primary Completion Date

October 8, 2018

Study Completion Date

October 8, 2018

Conditions

Fetuses With at Least 2 Malformations, and no Diagnosis After Fetopathological and Radiological Examinations

Interventions

OTHER

Sample of a fragment of fetal tissue

OTHER

Parent's blood samples

Trial Locations (10)

21079

CHU de DIJON, Dijon

34000

CHU Montpellier, Montpellier

35203

CHU de Rennes, Rennes

37000

CHRU de Tours, Tours

51092

CHRU de Reims (Hôpital Maison Blanche), Reims

54511

CHU de NANCY, Vandœuvre-lès-Nancy

63000

CHU de Clermont-Ferrand, Clermont-Ferrand

67098

CHU de STRASBOURG (Hôpital Hautepierre), Strasbourg

68070

CH de Mulhouse (Hôpital Emile Muller), Mulhouse

76000

CHU de Rouen, Rouen

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02512354 - Contribution of High-throughput Exome Sequencing in the Diagnosis of the Cause Fetal Polymalformation Syndromes | Biotech Hunter | Biotech Hunter